01.03.2011 • News

Andrew Liveris To Leave Citi Board

Dow Chemicals Andrew Liveris will not stand for re-election Citibanks annual...
Dow Chemical's Andrew Liveris will not stand for re-election Citibank's annual meeting on April 21.

Dow Chemical Chief Executive Andrew Liveris will leave Citigroup board of directors in April, the bank said in a regulatory filing on Monday. Liveris will not stand for re-election at the bank's annual meeting on April 21, according to the filing.

The head of the largest U.S. chemical maker, Liveris joined Citigroup's board in 2005 and was one of the few remaining directors from before the financial crisis. He is also on the IBM board of directors.

Regulators pressed the bank to add more directors with financial experience during the crisis, as massive losses forced Citigroup to take $45 billion in U.S. bailout funds. Last month, the bank reported its first full-year profit since 2007.

 

Interview

The UK Chemical Supply Chain
Trade and Competitiveness

The UK Chemical Supply Chain

The CBA, led by CEO Tim Doggett, is steering the UK chemical supply chain through trade uncertainty, sustainability pressures and logistics challenges, as he explains in this interview with CHEManager.

Expert Insights

ADCs for Precision Cancer Therapy
Comprehensive Insights into Antibody–Drug Conjugates

ADCs for Precision Cancer Therapy

Explore how antibody-drug conjugates are reshaping precision cancer therapy and discover what it takes to successfully develop, manufacture, and scale these complex biologics.

most read

Photo

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.